info@sami-sabinsagroup.com +91 80 2839 7973 - 75 Careers
Sami-Sabinsa Group | Formerly Sami Labs Limited -
  • Home
  • About Us
    • Our Story
    • Our People
    • Milestones
    • Manufacturing Facilities
    • Research & Development
    • Intellectual Properties
    • Associated Companies
    • Awards
  • Products & Services
    • Nutraceutical Ingredients
    • Standardized Phyto Extracts
    • Beverage/Liquid Dietary Ingredients
    • GRAS Affirmed Products
    • Minerals for Nutritional Use
    • Multi-enzyme Blends
    • Natural Protein
    • Nutritional Fine Chemicals
    • Nutritional Ingredient Blends
    • Prebiotics, Probiotics & Synbiotics
    • Super Critical Fluid (SCF) Extracts
    • Specialty Chemicals
    • Cosmeceutical Ingredients
    • Natural Actives
    • Anti-glycation
    • Dermaceuticals
    • Nutricosmetics
    • Probiotics & Postbiotics
    • Specialty Chemicals
    • Proprietary Cosmeceutical Blends
    • Services
    • Contract Farming
    • Contract Research
    • Pharma
    • Natural Drugs
    • Chiral Drug Intermediates
  • Newsroom
    • Announcements
    • Press Releases
    • Media Coverage
    • Ads
    • Events
    • Articles
    • White Papers
    • Visit by Dr. Kalam
    • Videos
  • CSR
  • Contact Us
  • Locations
    • USAUSA
    • AustraliaAustralia
    • CanadaCanada
    • ChinaChina
    • EuropeEurope
    • JapanJapan
    • KoreaKorea
    • PolandPoland
    • South AfricaSouth Africa

Sabinsa Named a Top New Jersey Company for Its Dynamic Growth

Sabinsa Named a Top New Jersey Company for Its Dynamic Growth Sabinsa Named a Top New Jersey Company for Its Dynamic Growth

December 6, 2019

Sabinsa Issued New U.S. Patent for LactoSpore® Based upon Published Research Confirming Ability to Reverse Depression Symptoms in Patients Suffering from IBS

Sabinsa Issued New U.S. Patent for LactoSpore® Based upon Published Research Confirming Ability to Reverse Depression Symptoms in Patients Suffering from IBS Sabinsa Issued New U.S. Patent for LactoSpore® Based upon Published Research Confirming Ability to Reverse Depression Symptoms in Patients Suffering from IBS

December 3, 2019

Sabinsa’s Pterostilbene in Silbinol® Subject of Published Study

Sabinsa’s Pterostilbene in Silbinol® Subject of Published Study Sabinsa’s Pterostilbene in Silbinol® Subject of Published Study

November 18, 2019

Sabinsa’s Parent Dubbed Most Trusted Nutraceutical Company

Sabinsa’s Parent Dubbed Most Trusted Nutraceutical Company Sabinsa’s Parent Dubbed Most Trusted Nutraceutical Company

November 12, 2019

Government of Karnataka State, India Recognizes the Sami- Sabinsa Group with Three Awards for Export Excellence

Government of Karnataka State, India Recognizes the Sami- Sabinsa Group with Three Awards for Export Excellence Government of Karnataka State, India Recognizes the Sami- Sabinsa Group with Three Awards for Export Excellence

November 4, 2019

Research Finds Sabinsa’s Curcumin C3 Complex® in Combination with BioPerine® Effective for Non-Alcoholic Fatty Liver Disease

Research Finds Sabinsa’s Curcumin C3 Complex® in Combination with BioPerine® Effective for Non-Alcoholic Fatty Liver Disease Research Finds Sabinsa’s Curcumin C3 Complex® in Combination with BioPerine® Effective for Non-Alcoholic Fatty Liver Disease

October 30, 2019
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Latest Press Release

  • New Research Published on Sami-Sabinsa’s Curcumin C3 Reduct® Supports Efficacy as an Oral Care Ingredient New Research Published on Sami-Sabinsa’s Curcumin C3 Reduct® Supports Efficacy as an Oral Care Ingredient Date: January 25, 2021
    ( 0 Votes ) 
  • Sami-Sabinsa Top Scientist Gives Presentation to U.S. FDA Sami-Sabinsa Top Scientist Gives Presentation to U.S. FDA Date: January 21, 2021
    ( 0 Votes ) 
  • Sami-Sabinsa Expands IP Portfolio with Five New U.S. Patents, Two CII Awards for IP Portfolio, and Dr. Majeed Honored by IASTAM Sami-Sabinsa Expands IP Portfolio with Five New U.S. Patents, Two CII Awards for IP Portfolio, and Dr. Majeed Honored by IASTAM Date: December 22, 2020
    ( 0 Votes ) 
  • Sami-Sabinsa’s Macumax® Formula Demonstrates Vision Health Benefits in Published Study Sami-Sabinsa’s Macumax® Formula Demonstrates Vision Health Benefits in Published Study Date: December 17, 2020
    ( 1 Vote ) 
  • Sami-Sabinsa Founder Honored by ASSOCHAM for Lifetime Achievement Sami-Sabinsa Founder Honored by ASSOCHAM for Lifetime Achievement Date: December 7, 2020
    ( 0 Votes ) 

Other Press Release

  • Press Release 2020
  • Press Release 2019
  • Press Release 2018
  • Press Release 2017
  • Press Release 2016
  • Press Release 2015
  • Press Release 2014
  • Press Release 2013
  • Press Release 2012
  • Press Release 2011
  • Press Release 2010
  • Press Release 2009
  • Press Release 2008
  • Press Release 2007
  • Press Release 2006
  • Press Release 2005
  • Press Release 2004
  • Press Release 2003
  • Press Release 2002
  • Press Release 2001
  • Press Release 2000
  • Press Release 1999
  • Press Release 1998
  • Press Release 1997
  • Press Release 1996
  • Press Release 1995

About

Founded by Dr. Muhammed Majeed, an internationally acclaimed scientist, entrepreneur and pioneer in the field of evidence-based natural ingredients, Sami-Sabinsa Group is a research-oriented multinational health science company.

Certificates

burea-veritas-certified dsir-certified ficci-certified fsrn-certified fssc-certified health-canada-certified halal-certified kosher-certified usp-certified

Global Contacts List

Australia Korea
Brasil Poland
Canada South Africa
China New Jersey, USA
Germany Utah, USA
Japan Vietnam

Get in Touch

19/1 & 19/2
Ⅰ Main, Ⅱ Phase
Peenya Industrial Area
Bangalore 560058, India
info@sami-sabinsagroup.com
+91 80 2839 7973 - 75
+91 80 2837 3035

© 2021 Sami-Sabinsa Group. All Rights Reserved.

Scroll to Top
Powered by Edkal Technologies | Privacy Policy | Terms of Use | Sitemap | Disclaimer
Disclaimer

US-FDA: This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Usage disclaimer: The information pertaining to any marketing materials by Sabinsa, is for general purposes only. Users are urged to check the validity of patents if any, on any Sabinsa items for their intended use.

EFSA: This statement has not been evaluated by the EFSA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Australia: Please note as an ingredient supplier the information contained in this website is for marketers of finished products formulations and is not intended as consumer advice. Marketers should ensure finished products are lawful and comply with the regulations of the countries in which these items are sold. Every care has been taken to ensure the accuracy of the information provided at the time of publication.

We use cookies to ensure that we give you the best experience on our website. For more details visit our Privacy Policy
I accept